CORRECTION OF ANAEMIA WITH ERYTHROPOIETIN IN CKD/ESRD PATIENTS

Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2015, Vol 4, Issue 12

Abstract

  Chronic kidney disease (CKD) is characterized by gradual and permanent loss of kidney function. One of the most common complications of CKD is Anaemia.1,3 Anaemia often appears earlier in course of CKD and worsens with disease progression.1,2 Erythropoietin is a hormone synthesized in the kidney is deficient in the majority of patients of CKD thereby predisposing them for developing anaemia. Erythropoiesis stimulating agents ESAs) first became clinically available in 1989 and has contributed to the advances in the management of CKD related anemia. The present study highlights the correction of anaemia with erythropoietin (Eprex) in population having CKD on MHD and anaemia. Based on GFR CKD is divided into five stages from 1-5. Patients often become anaemic at stage 3 or 4 CKD but anaemia may develop as early as stage 2. And it is present in the majority of patients with stage 5 disease.2,4 The objective of this study is to evaluate efficacy of administration of 10000.U. Epotin alfa sc for once a week as initiation therapy in patients with anaemia of CKD/ESRD on MHD for 28 weeks of duration of treatment. It is a prospective study done at Central Hospital, South Central Railway, Secunderabad on patients with ESRD or stage 4 on maintenance hemodialysis and receiving subcutaneously EPO (Eprex). Serum feritin and %transferrin saturation are estimated before the initiation of EPO(Eprex) & if the levels are below normal, IV IRON 100 mg is given once weekly and oral elemental Iron 200 to 400 mg to every to normalize the serum ferritin and % transferrin saturation levels. Hemoglobin level estimation has done before and after the initiation of the EPO (Eprex) and once in weekly and four weekly to see the response more than 1gm in four weeks to achieve the target hemoglobin level (11 to 12 grams) in 28 weeks. In the present study target hemoglobin level (11-12g/dl) was achieved in 42 out of 50 patients under consideration (84%) in 28 weeks of duration of treatment and not achieved for 8 amongst 50(16%) patients. Increase in the hemoglobin level of 1/dl is seen in 13(26%),>1 g/dl in 29(58%) and <1 g/dl in 8(16%) patients.

Authors and Affiliations

Madhukar Gaikwad, Shyamal Sinha, Rashmi Sinha, Anitha Gore, Bhattacharjee S, Anjaiah T, Abdul Hannan, Kunal Patankar

Keywords

Related Articles

A CASE REPORT - RETROPERITONEAL DERMOID 

 Dermoid cyst comprises tissue derived from all the three germ cell layer of the embryo and can include many tissue types. Most are benign, but any of the tissue present can undergo malignant transformation. The...

 SCLERAL FIXATION IOL: OUTCOME AND COMPLICATIONS

 BACKGROUND To assess the visual outcome and complications in patients after Scleral fixation of intra ocular lens in 30 eyes (28 pts., 2 patients bilateral). METHODS This experimental study was conducted at SDE...

PAP SMEAR AS A SCREENING TOOL FOR EVALUATING CERVICAL DYSPLASIA AND MALIGNANCY- A HOSPITAL-BASED STUDY

BACKGROUND In women, cervical cancer is one of the most common cancers and the most researched disease. Pap smear is a cost-effective method for regular screening of population for early detection of pre-neoplastic and n...

PROFILE OF BACTERIAL ISOLATES IN NEONATAL BLOOD CULTURE AND THEIR ANTIBIOTIC SUSCEPTIBILITY PATTERNS (ANTIBIOGRAM) IN NEONATAL SEPSIS AT A TERTIARY CARE HOSPITAL NICU IN SOUTH INDIA

BACKGROUND Neonatal sepsis is one of the major causes of morbidity and mortality in neonates. The spectrum of bacterial pathogens causes Neonatal sepsis and their antibiotic sensitivity patterns vary from hospital to hos...

A DESCRIPTIVE STUDY ON THE CLINICAL MANIFESTATIONS AND SEVERITY OF PSORIASIS IN PATIENTS PRESENTING TO DERMATOLOGY OPD OF A TERTIARY HEALTH CARE CENTER IN CENTRAL KERALA

BACKGROUND Psoriasis is heterogeneous in its history, manifestations, presenting age, sites affected and environmental triggers. It presents as small localized lesions to generalized exfoliation type. An understanding of...

Download PDF file
  • EP ID EP106419
  • DOI 10.14260/jemds/2015/280
  • Views 101
  • Downloads 0

How To Cite

Madhukar Gaikwad, Shyamal Sinha, Rashmi Sinha, Anitha Gore, Bhattacharjee S, Anjaiah T, Abdul Hannan, Kunal Patankar (2015).   CORRECTION OF ANAEMIA WITH ERYTHROPOIETIN IN CKD/ESRD PATIENTS. Journal of Evolution of Medical and Dental Sciences, 4(12), 1927-1935. https://europub.co.uk/articles/-A-106419